J.I. Herrero

6.0k total citations
130 papers, 3.4k citations indexed

About

J.I. Herrero is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, J.I. Herrero has authored 130 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Epidemiology, 57 papers in Hepatology and 44 papers in Surgery. Recurrent topics in J.I. Herrero's work include Liver Disease Diagnosis and Treatment (39 papers), Liver Disease and Transplantation (36 papers) and Organ Transplantation Techniques and Outcomes (35 papers). J.I. Herrero is often cited by papers focused on Liver Disease Diagnosis and Treatment (39 papers), Liver Disease and Transplantation (36 papers) and Organ Transplantation Techniques and Outcomes (35 papers). J.I. Herrero collaborates with scholars based in Spain, United States and United Kingdom. J.I. Herrero's co-authors include Jorge Quiroga, Bruno Sangro, Jesús Prìeto, Fernando Pardo, Fernando Rotellar, Mercedes Iñarrairaegui, Javier A. Cienfuegos, Delia D’Avola, Alberto Benito and José Ignacio Bilbao and has published in prestigious journals such as PLoS ONE, Hepatology and Clinical Infectious Diseases.

In The Last Decade

J.I. Herrero

127 papers receiving 3.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
J.I. Herrero	1.9k	1.6k	1.4k	574	539	130	3.4k
Rachel Pedersen	1.6k 0.8×	1.9k 1.2×	1.2k 0.9×	445 0.8×	328 0.6×	39	2.9k
J. Klempnauer	1.2k 0.6×	845 0.5×	1.4k 1.0×	660 1.1×	452 0.8×	144	3.4k
Fady M. Kaldas	1.9k 1.0×	1.2k 0.8×	2.1k 1.5×	429 0.7×	294 0.5×	120	3.5k
Andrea Risaliti	1.0k 0.5×	733 0.5×	1.4k 1.0×	322 0.6×	368 0.7×	150	2.6k
Michele Masetti	1.0k 0.5×	693 0.4×	2.0k 1.4×	413 0.7×	732 1.4×	132	3.2k
Bernard de Hemptinne	2.6k 1.3×	1.2k 0.7×	3.1k 2.3×	411 0.7×	637 1.2×	197	4.6k
Silvio Nadalin	3.2k 1.7×	1.5k 0.9×	3.2k 2.3×	498 0.9×	865 1.6×	215	5.3k
Emiliano Giostra	3.3k 1.7×	2.8k 1.7×	1.7k 1.2×	214 0.4×	1.0k 1.9×	115	5.0k
Jorge Reyes	1.1k 0.6×	668 0.4×	2.5k 1.8×	1.3k 2.3×	537 1.0×	113	4.3k
Aurelio Sonzogni	1.7k 0.9×	1.9k 1.2×	1.2k 0.9×	145 0.3×	528 1.0×	102	5.0k

Countries citing papers authored by J.I. Herrero

Since Specialization

Citations

This map shows the geographic impact of J.I. Herrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.I. Herrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.I. Herrero more than expected).

Fields of papers citing papers by J.I. Herrero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.I. Herrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.I. Herrero. The network helps show where J.I. Herrero may publish in the future.

Co-authorship network of co-authors of J.I. Herrero

This figure shows the co-authorship network connecting the top 25 collaborators of J.I. Herrero. A scholar is included among the top collaborators of J.I. Herrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.I. Herrero. J.I. Herrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Riezu‐Boj, José Ignacio, Fermı́n I. Milagro, J.I. Herrero, et al.. (2024). Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial. Clinical Nutrition. 43(7). 1770–1781. 7 indexed citations

Riezu‐Boj, José Ignacio, Fermı́n I. Milagro, J.I. Herrero, et al.. (2024). Multipanel Approach including miRNAs, Inflammatory Markers, and Depressive Symptoms for Metabolic Dysfunction-Associated Steatotic Liver Disease Diagnosis during 2-Year Nutritional Intervention. Nutrients. 16(11). 1547–1547. 4 indexed citations

Milagro, Fermı́n I., Mariana Elorz, Alberto Benito, et al.. (2024). Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessment. Journal of Physiology and Biochemistry. 81(4). 1275–1288. 7 indexed citations

Riezu‐Boj, José Ignacio, Fermı́n I. Milagro, J.I. Herrero, et al.. (2024). Circulating microRNA panels in subjects with metabolic dysfunction-associated steatotic liver disease after following a 2-year dietary intervention. Journal of Endocrinological Investigation. 48(4). 987–1003. 2 indexed citations

Perdomo, Carolina M., Nerea Martín‐Calvo, Ana Ezponda, et al.. (2024). Epicardial and liver fat implications in albuminuria: a retrospective study. Cardiovascular Diabetology. 23(1). 308–308. 1 indexed citations

Riezu‐Boj, José Ignacio, Fermı́n I. Milagro, J.I. Herrero, et al.. (2024). Sex-Dependent Gut Microbiota Features and Functional Signatures in Metabolic Disfunction-Associated Steatotic Liver Disease. Nutrients. 16(23). 4198–4198. 7 indexed citations

Ezponda, Ana, María José García‐Velloso, María D. Lozano, et al.. (2023). Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients. Liver Transplantation. 29(10). 1100–1108. 1 indexed citations

Appenzeller‐Herzog, Christian, Tim Mathes, Alberto Baroja‐Mazo, et al.. (2023). Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta‐analysis. Liver International. 44(1). 250–262. 2 indexed citations

Aliseda, Daniel, Pablo Martí‐Cruchaga, Gabriel Zozaya, et al.. (2023). Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience. Cancers. 15(3). 733–733. 12 indexed citations

10.

Rodríguez‐Perálvarez, Manuel, Jordi Colmenero, Antonio González, et al.. (2022). Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation. American Journal of Transplantation. 22(6). 1671–1682. 59 indexed citations

11.

Baroja‐Mazo, Alberto, Beatriz Revilla‐Nuin, L. Martínez‐Alarcón, et al.. (2018). Extracellular adenosine reversibly inhibits the activation of human regulatory T cells and negatively influences the achievement of the operational tolerance in liver transplantation. American Journal of Transplantation. 19(1). 48–61. 22 indexed citations

12.

Herrero, J.I., Valentín Cuervas‐Mons, Miguel Ángel Gómez‐Bravo, et al.. (2018). Prevalence and progression of chronic kidney disease after a liver transplant: a prospective, real-life, observational, two-year multicenter study. Revista Española de Enfermedades Digestivas. 110(9). 538–543. 8 indexed citations

13.

Garza, Rocío García de la, Pablo Sarobe, Juana Merino, et al.. (2013). Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance. Liver Transplantation. 19(9). 937–944. 70 indexed citations

14.

Rodríguez–Lago, Iago, Delia D’Avola, Mercedes Iñarrairaegui, et al.. (2012). Rhabdomyolysis after Intentional Acetaminophen and Carbon Monoxide Poisoning. Journal of Gastroenterology and Hepatology Research. 1(6). 111–113.

15.

Corral, Luisa, Casimiro Javierre, Josep L. Ventura, et al.. (2012). Impact of non-neurological complications in severe traumatic brain injury outcome. Critical Care. 16(2). R44–R44. 124 indexed citations

16.

Nashan, Björn, Faouzi Saliba, François Durand, et al.. (2009). Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients. Liver Transplantation. 15(2). 136–147. 32 indexed citations

17.

Mazzolini, Guillermo, Carlos Alfaro, Bruno Sangro, et al.. (2005). 1134. Intratumoral Injection of Dendritic Cells Engineered to Secrete Interleukin-12 by Recombinant Adenovirus in Patients with Metastatic Gastrointestinal Carcinomas. Molecular Therapy. 11. S437–S438. 5 indexed citations

18.

Herrero, J.I., Jorge Quiroga, Bruno Sangro, et al.. (2003). Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus. Transplantation Proceedings. 35(5). 1877–1879. 12 indexed citations

19.

Herrero, J.I., Jorge Quiroga, Bruno Sangro, et al.. (1999). Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil. Liver Transplantation and Surgery. 5(5). 414–420. 91 indexed citations

20.

Redondo, Pedro, Agustı́n España, J.I. Herrero, et al.. (1993). Graft-versus-host disease after liver transplantation. Journal of the American Academy of Dermatology. 29(2). 314–317. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact